CalciMedica, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
CalciMedica, Inc. (CALC) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $540.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-11
- CalciMedica, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $540.00K, a 54.00% decline year-over-year.
- CalciMedica, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $561.00K, a 2.19% increase year-over-year.
- CalciMedica, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $626.00K, a 19.85% decline year-over-year.
- CalciMedica, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $1.17M, a 141.56% increase year-over-year.
- CalciMedica, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $2.97M, a 28.45% increase from fiscal 2024.
- CalciMedica, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $2.31M, a 80.79% decline from fiscal 2023.
- CalciMedica, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $12.04M, a 569.21% increase from fiscal 2022.
- CalciMedica, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $1.80M, a 66.53% decline from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month as first filed | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $540.00K 10-Q · filed 2026-08-11 | $1.10M derived: sum of 2 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | $561.00K 10-Q · filed 2026-08-11 | |||||
| 2025-12-31 | $2.97M 10-K · filed 2026-03-03 | |||||
| 2025-09-30 | $626.00K 10-Q · filed 2025-11-12 | $1.80M derived: sum of 2 quarters · filed 2026-08-11 | $2.35M derived: sum of 3 quarters · filed 2026-08-11 | |||
| 2025-06-30 | $1.17M 10-Q · filed 2026-08-11 | $1.72M derived: sum of 2 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | $549.00K 10-Q · filed 2026-08-11 | |||||
| 2024-12-31 | $2.31M 10-K · filed 2026-03-03 | |||||
| 2024-09-30 | $781.00K 10-Q · filed 2025-11-12 | $1.27M derived: sum of 2 quarters · filed 2025-11-12 | $1.68M derived: sum of 3 quarters · filed 2025-11-12 | |||
| 2024-06-30 | $486.00K 10-Q · filed 2025-11-12 | $900.00K derived: sum of 2 quarters · filed 2025-11-12 | ||||
| 2024-03-31 | $414.00K 10-Q · filed 2025-11-12 | |||||
| 2023-12-31 | $12.04M 10-K · filed 2025-03-27 | |||||
| 2023-09-30 | $482.00K 10-Q · filed 2024-11-13 | $945.00K derived: sum of 2 quarters · filed 2024-11-13 | $12.07M derived: sum of 3 quarters · filed 2024-11-13 | |||
| 2023-06-30 | $463.00K 10-Q · filed 2024-11-13 | $11.59M derived: sum of 2 quarters · filed 2024-11-13 | ||||
| 2023-03-31 | $11.13M 10-Q · filed 2024-11-13 | |||||
| 2022-12-31 | $1.80M 10-K · filed 2024-03-28 | $6.71M 10-K · filed 2023-03-09 | ||||
| 2022-09-30 | $757.00K 10-Q · filed 2023-11-09 | $1.68M 10-Q · filed 2022-11-10 | $1.08M derived: sum of 2 quarters · filed 2023-11-09 | $1.41M derived: sum of 3 quarters · filed 2023-11-09 | ||
| 2022-06-30 | $321.00K 10-Q · filed 2023-11-09 | $1.75M 10-Q · filed 2022-08-12 | $656.00K derived: sum of 2 quarters · filed 2023-11-09 | |||
| 2022-03-31 | $335.00K 10-Q · filed 2023-11-09 | $1.54M 10-Q · filed 2022-05-12 | ||||
| 2021-12-31 | $5.38M 10-K · filed 2023-03-09 | |||||
| 2021-09-30 | $1.43M 10-Q · filed 2022-11-10 | $2.74M derived: sum of 2 quarters · filed 2022-11-10 | $3.87M derived: sum of 3 quarters · filed 2022-11-10 | |||
| 2021-06-30 | $1.31M 10-Q · filed 2022-11-10 | $2.44M derived: sum of 2 quarters · filed 2022-11-10 | ||||
| 2021-03-31 | $1.13M 10-Q · filed 2022-11-10 | |||||
| 2020-12-31 | $1.79M 10-K · filed 2022-03-11 | |||||
| 2020-09-30 | $561.00K 10-Q · filed 2021-11-12 | $775.00K derived: sum of 2 quarters · filed 2021-11-12 | $1.00M derived: sum of 3 quarters · filed 2021-11-12 | |||
| 2020-06-30 | $214.00K 10-Q · filed 2021-11-12 | $440.00K derived: sum of 2 quarters · filed 2021-11-12 | ||||
| 2020-03-31 | $226.00K 10-Q · filed 2021-11-12 | |||||
| 2019-12-31 | $738.00K 10-K · filed 2021-03-05 | |||||
| 2019-09-30 | $250.00K 10-Q · filed 2020-11-12 | $392.00K derived: sum of 2 quarters · filed 2020-11-12 | $548.00K derived: sum of 3 quarters · filed 2020-11-12 | |||
| 2019-06-30 | $142.00K 10-Q · filed 2020-11-12 | $298.00K derived: sum of 2 quarters · filed 2020-11-12 | ||||
| 2019-03-31 | $156.00K 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |